Svenja Hardtke

7PUBLICATIONS
33CO-AUTHORS
Medical virologyMajor global burdens of diseaseMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Nutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 09, 2026
Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults.

Leonie Mayer, Anahita Fathi, Hanna-Marie Weichel

|Nov 29, 2025
Ten-Year Follow-Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT-II): Improved Clinical Outcome After Combination Therapy.

Cihan Yurdaydin, Julia Kahlhöfer, Florin Alexandru Caruntu

|Jan 26, 2024
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans.

Leonie Mayer, Leonie M Weskamm, Anahita Fathi

|Jun 19, 2023
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients.

André Gömer, Mara Klöhn, Michelle Jagst

|Feb 04, 2020
MAIT Cells Are Enriched and Highly Functional in Ascites of Patients With Decompensated Liver Cirrhosis.

Christian E Niehaus, Benedikt Strunz, Martin Cornillet

|Aug 01, 2018
Risk factors and seroprevalence of hepatitis E evaluated in frozen-serum samples (2002-2003) of pregnant women compared with female blood donors in a Southern region of Brazil.

S Hardtke, R Rocco, J Ogata

Pageof 2

Frequent Collaborators

3 joint publications

Heiner Wedemeyer

3 joint publications

Markus Cornberg

2 joint publications

Marylyn M Addo

2 joint publications

Leonie M Weskamm